Pain intensity* (VAS Patient) | HAQ | DAS 28 | ||||
---|---|---|---|---|---|---|
RF | seropos. | seroneg. | seropos. | seroneg. | seropos. | seroneg. |
Baseline | 59.8 (N=285) | 54.3 (N=29) | 1.6 (N=239) | 1.5 (N=24) | 5.6 (N=286) | 5.3 (N=29) |
Day 15 | 49.9 (N=237) | 52.7 (N=27) | 1.4 (N=191) | 1.4 (N=21) | 5.1 (N=194) | 5.0 (N=16) |
Week 6 | 43.9 (N=184) | 42.3 (N=23) | 1.4 (N=150) | 1.4 (N=18) | 4.6 (N=140) | 4.4 (N=17) |
Week 12 | 35.3 (N=180) | 34.9 (N=20) | 1.2 (N=149) | 1.2 (N=16) | 4.1 (N=149) | 4.3 (N=13) |
Week 18 | 33.5 (N=159) | 36.2 (N=18) | 1.2 (N=139) | 1.1 (N=15) | 3.9 (N=120) | 3.7 (N=10) |
Week 24 | 34.9 (N=210) | 39.6 (N=22) | 1.3 (N=172) | 1.1 (N=19) | 3.9 (N=163) | 4.0 (N=14) |
*100 = intolerable pain.